Alejandro Dorenbaum
- Virology top 2%
- HIV Research and Treatment 8
- Infectious Diseases top 2%
- HIV/AIDS Research and Interventions 10
- HIV/AIDS drug development and treatment 7
- Hepatology top 5%
- Emergency Medicine top 5%
- Physiology top 10%
- Asthma and respiratory diseases 4
-
- Pediatric Hepatobiliary Diseases and Treatments 8
-
- Drug Transport and Resistance Mechanisms 8
-
- Respiratory and Cough-Related Research 4
-
- Metabolism and Genetic Disorders 3
- Co-authors
- Tmirah HaselkornBradley E. ChippsRobert S. ZeigerWansu ChenJin–Wen Y. HsuMichael SchätzDave P. MillerMark Mirochnick
- Journals
- Journal of Allergy and Clinical Immunology (3 papers)Journal of Hepatology (3 papers)Hepatology Communications (3 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Alejandro Dorenbaum
38 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 108
- Virology 246
- Infectious Diseases 646
- Hepatology 182
- Emergency Medicine 154
- Physiology 345
Countries citing papers authored by Alejandro Dorenbaum
This map shows the geographic impact of Alejandro Dorenbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro Dorenbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro Dorenbaum more than expected).
Fields of papers citing papers by Alejandro Dorenbaum
This network shows the impact of papers produced by Alejandro Dorenbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro Dorenbaum. The network helps show where Alejandro Dorenbaum may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alejandro Dorenbaum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 22 | |
| 2 | 2022 | 39 | |
| 3 | 2021 | 103 | |
| 4 | DURABILITY OF TREATMENT EFFECT WITH LONG-TERM MARALIXIBAT IN CHILDREN WITH ALAGILLE SYNDROME: 4-YEAR SAFETY AND EFFICACY RESULTS FROM THE ICONIC STUDY | 2019 | 1 |
| 5 | 2018 | 45 | |
| 6 | 2017 | 24 | |
| 7 | 2014 | 78 | |
| 8 | 2014 | 126 | |
| 9 | 2013 | 166 | |
| 10 | 2012 | 43 | |
| 11 | 2011 | 11 | |
| 12 | 2007 | 8 | |
| 13 | 2004 | 79 | |
| 14 | 2003 | 35 | |
| 15 | 2002 | 99 | |
| 16 | 2002 | 69 | |
| 17 | 2002 | 269 | |
| 18 | 2001 | 9 | |
| 19 | 1999 | 14 | |
| 20 | 1995 | 9 |
About Alejandro Dorenbaum
Alejandro Dorenbaum is a scholar working on Virology, Infectious Diseases, Clinical Biochemistry, Hepatology and Gastroenterology, having authored 40 papers that have together received 1.7k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (10 papers), Pediatric Hepatobiliary Diseases and Treatments (8 papers), HIV Research and Treatment (8 papers), Drug Transport and Resistance Mechanisms (8 papers), HIV/AIDS drug development and treatment (7 papers), Respiratory and Cough-Related Research (4 papers), Asthma and respiratory diseases (4 papers) and Metabolism and Genetic Disorders (3 papers). The work is most often cited by research in Virology (246 citations), Infectious Diseases (646 citations), Hepatology (182 citations), Emergency Medicine (154 citations) and Physiology (345 citations). Alejandro Dorenbaum has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Tmirah Haselkorn, Bradley E. Chipps, Robert S. Zeiger, Wansu Chen, Jin–Wen Y. Hsu, Michael Schätz, Dave P. Miller, Mark Mirochnick, Ciara Kennedy and Diane W. Wara. Their work appears in journals such as Journal of Allergy and Clinical Immunology, Journal of Hepatology, Hepatology Communications, JAIDS Journal of Acquired Immune Deficiency Syndromes and Sleep Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.